Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

ANROANRO
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ALTO NEUROSCIENCE INC

GOLDMAN SACHS GROUP INC holds 236,830 shares of ANRO (ALTO NEUROSCIENCE INC), worth $6.2M as of 2026-Q2. The position was increased (+126.2% shares). ANRO represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$6.2M

Current Shares

236,830

Total Value Change

+$5.8M

Total Shares Change

+125,553

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
236,830
+126.2%
$6.2M0.0%$26.39
44
2026-Q1
Decreased
104,717
-33.0%
$2.4M0.0%$20.11
0
2025-Q4
Increased
156,319
+73.2%
$2.8M0.0%$17.94
39
2025-Q3
Decreased
90,251
-45.7%
$362,8090.0%$4.01
0
2025-Q2
Increased
166,087
+65.5%
$365,3910.0%$2.31
24
2025-Q1
Decreased
100,374
-9.8%
$216,8080.0%$2.27
0
2024-Q4
New
111,277
-
$470,7020.0%$4.20
33

Other major holders of ANRO: BlackRock, Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., VANGUARD CAPITAL MANAGEMENT LLC, Point72 Asset Management, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used